Schroder Investment Management Group Lowers Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)

Schroder Investment Management Group trimmed its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 1.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 125,013 shares of the company’s stock after selling 1,768 shares during the quarter. Schroder Investment Management Group owned […]

Related Keywords

Samarth Kulkarni ,Jamesr Kasinger ,Headlands Technologies ,Bluepath Capital Management ,Tradewinds Capital Management ,Needham Company ,Geneos Wealth Management Inc ,Exchange Commission ,Wolfe Research ,Therapeutics Company Profile ,Schroder Investment Management Group ,Morgan Stanley ,Free Report ,Investment Management Group ,Wealth Management ,Capital Management ,Stock Down ,Get Free Report ,General Counsel James ,Chardan Capital ,